News Category
Dr. Lina Rugova's new podcast episode reveals that San Antonio's low international profile is costing the city global business opportunities, and she ...
Leona Tong's recognition as a Forbes China honoree highlights OPH Health's integrated medical device, software and AI approach to strengthening primar...
Catherine Cifuentes-Rojas releases a free early-stage go/no-go checklist for biotherapeutics teams to help them make data-driven decisions and avoid c...
The Seventh Beijing Forum on Evidence-Based Medicine and 2026 eCMTA Journal Symposium convened 28 experts from 14 countries to advance rigorous eviden...
Market Street Capital's specialized advisory services for middle-market healthcare companies are increasingly vital as reimbursement uncertainty and c...
VERAXA Biotech (NASDAQ: VRXA) is expanding its use of human-relevant preclinical testing methods across its antibody-based cancer drug programs, aimin...
Quantum BioPharma's agreement with Thermo Fisher's clinical research business moves its investigational progressive MS drug Lucid-MS toward Phase 2 im...
A dual-targeting antibody achieved profound effects in mice across multiple tumor types, offering a potential path to expand immunotherapy's reach to ...
SS Innovations demonstrated remote robotic cardiac surgery across 7,500 miles, underscoring the potential of tele-surgery to broaden access to special...
Neurologist Dr. Eric Anderson is drawing attention to central sensitization as a key driver of chronic back pain, and Lin Health's new research shows ...
Lapp Wagons LLC now ships its Speedway Express kid wagons, work wagons, and aftermarket wagon wheels nationwide at no extra cost, extending the life o...
Regentis Biomaterials' GelrinC hydrogel implant demonstrates superior pain improvement and cartilage repair quality compared to microfracture, positio...
Regentis Biomaterials is advancing GelrinC, a cell-free hydrogel implant that has demonstrated superior pain relief and cartilage repair quality versu...
Annovis Bio CEO Maria Maccecchini will present at two November conferences, highlighting the company's clinical programs and upcoming milestones for i...
Oncotelic is advancing its PLA-guided discovery engine from a published, independently validated four-gene liver cancer survival signature toward a 10...
TransCode Therapeutics has initiated a formal strategic review to evaluate options for maximizing the value of its oncology portfolio, including lead ...
Stocktwits' Stocktoberfest 2026 gathered over 350 attendees, including influential financial creators and executives, to foster collaboration across t...
A new American Heart Association grant funds Cedars-Sinai researchers to develop an AI-powered early warning system for out-of-hospital cardiac arrest...
SeABank's new Sustainable Finance Framework, backed by an S&P Global Ratings Second-Party Opinion, unifies green, blue, and social financing to accele...
Enodia Therapeutics has named Henrik Torp Nielsen as Chief Financial Officer to steer its financial strategy as the company advances its proprietary S...
Certified-PEP has published a 2026 comparison of 10 research peptide suppliers, revealing significant differences in documentation and transparency th...
The Dr. Leonard Hochstein Grant marks its namesake's 30-plus-year career in plastic surgery, emphasizing his surgical center, extensive experience, an...
Hallstat's plan to relocate manufacturing for its Foley catheter system closer to the U.S. aims to cut costs and shipping times while maintaining qual...
A Phase 3 trial shows that combining two immunotherapy drugs extends median survival in patients with a deadly form of lung cancer, signaling a potent...
HeartBeam will present results from its ALIGN-ACS pilot study of a credit card-sized 3D ECG device at TCT 2026, a key step toward a U.S. pivotal trial...
VolitionRx's nonbinding LOI with Missionpharma aims to develop and commercialize a low-cost, finger-prick NETosis test for neonatal sepsis, potentiall...
San Francisco Dental Implant Center's new content helps San Mateo and Peninsula residents identify optimal scheduling windows for all-on-four dental i...
Creative Biolabs is spotlighting functional complement assays and microfluidic droplet generation tools that help researchers address assay variabilit...
NanoViricides' Phase IIA trial of NV-387 Oral Gummies for Ebola Bundibugyo is progressing, with Phase IIB anticipated, offering a potential oral treat...
A mutated flu virus spreading early on the West Coast has prompted urgent vaccination calls and highlighted the role of decentralized testing tools fr...
Helus Pharma's co-founders have transitioned off executive roles and Mark Lawson was named independent board chair, a governance shift aimed at suppor...
Tonix Pharmaceuticals' Phase 3 RELIEF and RESILIENT studies demonstrate that TONMYA significantly improves pain, symptom severity, and physical functi...
GeoVax Labs has entered into a $1 million revolving loan agreement with Bowery Consulting Group, which includes the appointment of three new directors...
Creative Biolabs has introduced an integrated OMV and exosome-boosted CAR-T development platform to help researchers address poor infiltration, immuno...
Creative Biolabs highlights its tumor organoid and immune cell co-culture services, including CAR-T models, to address limitations of 2D cultures in i...
GeoVax Labs has entered a $1 million revolving loan agreement with Bowery Consulting Group, which includes board restructuring that gives the lender s...
Bronwyn Brophy O'Connor will become CEO of Carl Zeiss Meditec on December 1, 2026, succeeding interim CEO Andreas Pecher and bringing extensive medtec...
Viromed Medical AG raised approximately €2 million through a capital increase, issuing 450,000 new shares at €4.50 each to bolster working capital and...
PolyPeptide shareholders approved a full board reshuffle and removal of transfer restrictions, clearing the path for Samsung Biologics' tender offer a...
SS Innovations International showcased its SSi Mantra system by performing remote robotic surgeries across 7,500 miles, highlighting the potential to ...
HeartBeam's acceptance into the FDA's TAP Pilot Program could expedite regulatory review and patient access for its 3D ECG technology aimed at detecti...
SS Innovations International showcased its SSi Mantra system and SSi MantrAsana console in successful remote surgeries across two international confer...
TransCode Therapeutics' TTX-MC138 met its primary safety endpoint in Phase 1a trials, with no dose-limiting toxicities and early signs of disease stab...
Oncotelic Therapeutics announced a peer-reviewed study showing its AI platform identified a four-gene prognostic signature in liver cancer, which coul...
Tonix Pharmaceuticals will report third-quarter 2026 financial results on Nov. 9, giving investors a key update on the commercial rollout of its newly...
RC Medical's venture studio model, highlighted by CEO David Ferrera, builds new companies around physician-identified gaps in interventional radiology...
D. Boral Capital has initiated coverage on QT Imaging (NASDAQ: QTI) with a Buy rating and a $9 price target, citing growing adoption of its radiation-...
Coherence Neuro's $45 million Series A, backed by Peter Thiel and OpenAI, will fund the first chronic human trial of its SOMA implant for glioblastoma...
